Market Closed -
Bombay S.E.
06:00:50 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
550.2
INR
|
-0.89%
|
|
+7.75%
|
+4.68%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,123
|
4,299
|
1,982
|
2,554
|
2,407
|
3,406
|
Enterprise Value (EV)
1 |
3,867
|
3,972
|
1,684
|
2,099
|
1,874
|
3,109
|
P/E ratio
|
18.8
x
|
24.8
x
|
106
x
|
12.6
x
|
17.3
x
|
13.8
x
|
Yield
|
0.6%
|
0.63%
|
1.36%
|
1.18%
|
2.79%
|
1.18%
|
Capitalization / Revenue
|
1.26
x
|
1.43
x
|
0.74
x
|
0.93
x
|
0.69
x
|
0.77
x
|
EV / Revenue
|
1.18
x
|
1.32
x
|
0.63
x
|
0.76
x
|
0.54
x
|
0.71
x
|
EV / EBITDA
|
17
x
|
15.5
x
|
14.2
x
|
11.2
x
|
9.94
x
|
8.65
x
|
EV / FCF
|
-7.59
x
|
-22.5
x
|
-11.1
x
|
13.9
x
|
69
x
|
-43.5
x
|
FCF Yield
|
-13.2%
|
-4.44%
|
-9.05%
|
7.19%
|
1.45%
|
-2.3%
|
Price to Book
|
1.66
x
|
1.64
x
|
0.74
x
|
0.87
x
|
0.79
x
|
1.06
x
|
Nbr of stocks (in thousands)
|
13,448
|
13,448
|
13,448
|
13,448
|
13,448
|
13,448
|
Reference price
2 |
306.6
|
319.7
|
147.4
|
189.9
|
179.0
|
253.3
|
Announcement Date
|
7/17/18
|
7/9/19
|
7/7/20
|
6/29/21
|
7/12/22
|
7/26/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,275
|
3,013
|
2,680
|
2,744
|
3,494
|
4,404
|
EBITDA
1 |
226.9
|
255.7
|
118.8
|
187.1
|
188.5
|
359.7
|
EBIT
1 |
186.9
|
214.3
|
76.6
|
143.3
|
145.2
|
315.5
|
Operating Margin
|
5.71%
|
7.11%
|
2.86%
|
5.22%
|
4.15%
|
7.16%
|
Earnings before Tax (EBT)
1 |
279
|
244.1
|
78.92
|
285.3
|
205.4
|
336.6
|
Net income
1 |
219.7
|
173.2
|
18.73
|
203.4
|
139.2
|
246.9
|
Net margin
|
6.71%
|
5.75%
|
0.7%
|
7.41%
|
3.98%
|
5.61%
|
EPS
2 |
16.34
|
12.88
|
1.390
|
15.13
|
10.35
|
18.36
|
Free Cash Flow
1 |
-509.7
|
-176.4
|
-152.4
|
151
|
27.17
|
-71.48
|
FCF margin
|
-15.57%
|
-5.85%
|
-5.69%
|
5.5%
|
0.78%
|
-1.62%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
80.71%
|
14.41%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
74.21%
|
19.52%
|
-
|
Dividend per Share
2 |
1.850
|
2.000
|
2.000
|
2.250
|
5.000
|
3.000
|
Announcement Date
|
7/17/18
|
7/9/19
|
7/7/20
|
6/29/21
|
7/12/22
|
7/26/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
255
|
328
|
297
|
454
|
533
|
297
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-510
|
-176
|
-152
|
151
|
27.2
|
-71.5
|
ROE (net income / shareholders' equity)
|
9.48%
|
7.7%
|
1.14%
|
7.18%
|
4.66%
|
7.88%
|
ROA (Net income/ Total Assets)
|
3.62%
|
4.14%
|
1.49%
|
2.65%
|
2.54%
|
5.17%
|
Assets
1 |
6,074
|
4,186
|
1,260
|
7,680
|
5,486
|
4,777
|
Book Value Per Share
2 |
185.0
|
194.0
|
200.0
|
218.0
|
226.0
|
239.0
|
Cash Flow per Share
2 |
7.400
|
4.000
|
1.830
|
7.210
|
6.680
|
6.860
|
Capex
1 |
637
|
92.5
|
196
|
43.7
|
42.8
|
146
|
Capex / Sales
|
19.44%
|
3.07%
|
7.31%
|
1.59%
|
1.22%
|
3.32%
|
Announcement Date
|
7/17/18
|
7/9/19
|
7/7/20
|
6/29/21
|
7/12/22
|
7/26/23
|
|
1st Jan change
|
Capi.
|
---|
| +4.68% | 88.73M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|